Developer of innovative drugs for out-licensing to strategic pharmaceutical partners. The company was formed to provide Evolutionary Chemistry in the medical field. This technology can be used to identify and optimize potentially valuable chemicals and is particularly suited to the discovery and optimization of pharmaceutical products for human use. Pharmaceutical companies collaborate with the company to discover products for identified but unmet medical needs. Unlike any other drug discovery technology, Evolutionary Chemistry has the potential to generate new, high-value small-molecule drugs from novel libraries of five to 50 million compounds for virtually any therapeutic indication. The company's integrated drug discovery system combines the chemical synthesis with the power of evolution to rapidly discover optimized compounds for the increasing number of drug targets identified by ongoing genomics research.